Observational studyAnnals of African medicine2026
Role of Three-Tesla Cardiac Magnetic Resonance Imaging in the Evaluation of Cardiac Masses.
Observational study in Annals of African medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCardiac masses, though uncommon, pose significant diagnostic and therapeutic challenges. Accurate differentiation between benign and malignant masses is essential for appropriate management. Three-Tesla cardiac magnetic resonance (3T CMR) imaging offers superior soft tissue characterization and higher spatial resolution, enhancing diagnostic accuracy.
objectiveTo evaluate the diagnostic utility of 3T CMR in assessing cardiac masses, including mass characterization, associated findings, and agreement with echocardiography. MATERIALS AND
methodsThis prospective observational study was conducted at Dr. D. Y. Patil Medical College, Pune, from February 2023 to July 2025. Twenty patients with cardiac masses identified on echocardiography underwent 3T CMR. Data collected included demographic details, clinical profiles, CMR findings, and comparative analysis with two-dimensional (2D) echocardiography.
resultsThrombi were the most common mass (50%), followed by myxomas (20%). Masses most frequently involved the left ventricle and right atrium. Most masses were ill-defined and T1 hypointense. CMR identified pericardial effusion and myocardial infarction in 20% each. Agreement between 2D echo and CMR was moderate.
conclusion3T CMR is a valuable imaging modality in evaluating cardiac masses, providing comprehensive tissue characterization and detection of associated findings that impact management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.